HTFL

$26.02+0.13 (+0.50%)

Market ClosedAs of Mar 20, 8:00 PM UTC

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$26.02
Potential Upside
5%
Whystock Fair Value$27.32
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryHealth Information Services

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a pat...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.22B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-49.25%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
8.66

Recent News

GuruFocus.com
Mar 19, 2026

HeartFlow Inc (HTFL) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...

HeartFlow Inc (HTFL) reports a 40% revenue increase and unveils new AI-driven tools, setting the stage for continued expansion and competitive advantage.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MarketBeat
Mar 18, 2026

Heartflow Q4 Earnings Call Highlights

Heartflow (NASDAQ:HTFL) executives highlighted record revenue, accelerating adoption of its platform, and expanding reimbursement support during the company’s fourth-quarter 2025 earnings call, while also initiating 2026 guidance and outlining product and clinical milestones expected over the next y

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Associated Press Finance
Mar 18, 2026

HeartFlow: Q4 Earnings Snapshot

The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share. The medical technology company posted revenue of $49.1 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $46.6 million.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Insider Monkey
Mar 18, 2026

What Makes Heartflow (HTFL) an AI Beneficiary?

Baron Capital, an investment Management Company, released its fourth quarter 2025 investor letter for its “Baron Opportunity Fund”. A copy of the letter can be downloaded here. The Fund returned 4.63% (Institutional Shares) in Q4 2025, outperforming the Russell 3000 Growth Index’s (the Benchmark) 1.14% gain and the S&P 500 Index’s 2.66% return. The Fund […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
GuruFocus.com
Mar 17, 2026

Earnings To Watch: HeartFlow Inc (HTFL) Reports Q4 2025 Result

This article first appeared on GuruFocus. HeartFlow Inc (NASDAQ:HTFL) is set to release its Q4 2025 earnings on Mar 18, 2026. The consensus estimate for Q4 2025 revenue is $46.50 million, and the earnings are expected to come in at -$0.27 per share.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.